User Reviews for Insulin aspart
Also known as: Novolog, NovoLog FlexPen, NovoLog PenFill
The following information is NOT intended to endorse drugs or recommend therapy. While these reviews might be helpful, they are not a substitute for the expertise, skill, knowledge and judgement of healthcare practitioners in patient care.
Filter by:Learn more about Insulin aspart.
Condition  |
Reviews | Compare | Avg. Ratings |
|
|---|---|---|---|---|
| Diabetes, Type 2 | 3 reviews | 113 medications | 7.8 |
|
| Diabetes, Type 1 | 1 reviews | 66 medications | 7.5 |
|
| Summary | 4 reviews |
7.7
|
||
Reviews for Insulin aspart
| Review by Velton: |  | User Rating: |
9.0
|
|||
NovoLog FlexPen (insulin aspart) for Diabetes, Type 2: I have been on it for a little over 1 year and feel it has worked wonders for me.
|
||||||
| June 7, 2008 12:13 AM | ||||||
| Review by furretz: | | User Rating: |
10
|
|||
NovoLog FlexPen (insulin aspart) for Diabetes, Type 2: Convenient, easy to use....best blood glucose numbers!
|
||||||
| August 9, 2010 9:57 PM | ||||||
| Review by Scallywag: | | User Rating: |
8.0
|
|||
Novolog (insulin aspart) for Diabetes, Type 1: Novolog works very well and very fast (3-5) hours in lowering sugar levels but for those w/out insurance be wary Novolog is very expensive, espicially when you have to couple the insulin w/ another slow-acting, such as Lantus. Together these are very effective however.
|
||||||
| February 20, 2010 11:02 AM | ||||||
| Review by Anonymous: | | User Rating: |
3.0
|
|||
Novolog (insulin aspart) for Diabetes, Type 2: After trying several insulin types of medicines which caused severe itching, I was put on Novolog 70/30. At first there were no side effects, then dizziness started to occur and its getting worse, my ankles are starting to swell and I am putting on weight. I'm at my wits end. Novolog is very convenient to use, but unfortunately now I have to go back to doctor and start a new medication and go through trial and error with a new medication which can also be very costly.
|
||||||
| August 5, 2011 8:46 AM | ||||||
